In2Sight | First review meeting

April 29, 2022

The In2Sight Consortium held yesterday the First Review Meeting with experts from the European Innovation Council and SMEs Executive Agency (EISMEA), to follow-up on the project progress from the first year and to hear valuable recommendations from the experts.

The goal of the project is to foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.

The project is progressing and the first interesting results are starting to be published. Stay tuned for the next updates!

Check the project website for further information about In2Sight:

You can also contact us at:


Search News & Events

  • Filter by category


Related news and events

PragmaTIL | Kick-off meeting

The launch of the EU-funded PragmaTIL project took place recently in Barcelona. The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes

siNPAIN project | 2nd progress meeting

The siNPAIN project objective is to create a siRNA-combined advanced therapy, which will lead to more personalised treatment options for different stages of osteoarthritis.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting